Echocardiography in the potential heart donor

Transplantation

Volumn 89, Issue 7, 2010, Pages 894-901

  Venkateswaran, Rajamiyer V ^a   Townend, Jonathan N ^b   Wilson, Ian C ^a   Mascaro, Jorge G ^a   Bonser, Robert S ^a,c   Steeds, Richard P ^b  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Donor management; Echocardiography; Heart transplantation; Methylprednisolone; Tri iodothyronine

Indexed keywords

LIOTHYRONINE; METHYLPREDNISOLONE;

ADULT; ARTICLE; FEMALE; HEART; HEART EJECTION FRACTION; HEART INDEX; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE WALL; HEART TRANSPLANTATION; HEMODYNAMICS; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; POST HOC ANALYSIS; PRIORITY JOURNAL; PULMONARY ARTERY CATHETER; TRANSTHORACIC ECHOCARDIOGRAPHY;

ADULT; CATHETERIZATION, SWAN-GANZ; DONOR SELECTION; DOUBLE-BLIND METHOD; ECHOCARDIOGRAPHY; FEASIBILITY STUDIES; FEMALE; GRAFT SURVIVAL; HEART TRANSPLANTATION; HEMODYNAMICS; HUMANS; MALE; METHYLPREDNISOLONE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; STROKE VOLUME; SYSTOLE; THYROID FUNCTION TESTS; TIME FACTORS; TISSUE DONORS; TREATMENT OUTCOME; TRIIODOTHYRONINE; VENTRICULAR FUNCTION, LEFT;

EID: 77950950173     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181cfe8e9     Document Type: Article

References (25)

1. Taylor DO, Edwards LB, Boucek MM, et al. Registry of the International Society for Heart and Lung Transplantation: Twenty-fourth official adult heart transplant report-2007. J Heart Lung Transplant 2007; 26: 769.
2. Zaroff JG, Babcock WD, Shiboski SC. The impact of left ventricular dysfunction on cardiac donor transplant rates. J Heart Lung Transplant 2003; 22: 334.
3. Zaroff JG, Rosengard BR, Armstrong WF, et al. Consensus conference report: Maximizing use of organs recovered from the cadaver donor: Cardiac recommendations, March 28-29, 2001, Crystal City, Va. Circulation 2002; 106: 836.
4. Wheeldon DR, Potter CD, OduroA,et al. Transforming the "unacceptable" donor: Outcomes from the adoption of a standardized donor management technique. J Heart Lung Transplant 1995; 14: 734.
5. Wood KE, Becker BN, McCartney JG, et al. Care of the potential organ donor. N Engl J Med 2004; 351: 2730.
6. Sopko N, Shea KJ, Ludrosky K, et al. Survival is not compromised in donor hearts with echocardiographic abnormalities. J Surg Res 2007; 143: 141.
7. Gilbert EM, Krueger SK, Murray JL, et al. Echocardiographic evaluation of potential cardiac transplant donors. J Thorac Cardiovasc Surg 1988; 95: 1003.
8. Dujardin KS, McCully RB, Wijdicks EFM, et al. Myocardial dysfunction associated with brain death: Clinical, echocardiographic, and pathologic features. J Heart Lung Transplant 2001; 20: 350.
9. Babcock WD, Menza RL, Zaroff JG. Serial echocardiography increase donor heart utilization. J Heart Lung Transplant 2003; 22: 74.
10. Rosendale JD, Kauffman HM, McBride MA, et al. Aggressive pharma-cologic donor management resultsinmore transplanted organs.Transplantation 2003; 75: 482.
11. Venkateswaran RV, Steeds RP, Quinn DW, et al. The haemodynamic effects of adjunctive hormone therapy in potential heart donors: A prospective randomized double blind factorially designed controlled trial. Eur Heart J 2009; 30: 1771.
12. Potter CD, Wheeldon DR, Wallwork J. Functional assessment and management of heart donors: A rationale for characterization and a guide to therapy. J Heart Lung Transplant 1995; 14: 59.
13. Tei C, Ling LH, Hodge DO, et al. New index of combined systolic and diastolic myocardial performance: A simple and reproducible measure of cardiac function\A study in normals and dilated cardiomyopathy. J Cardiol 1995; 26: 357.
14. Goland S, Czer LSC, Kass RM, et al. Use of cardiac allografts with mild and moderate left ventricular hypertrophy can be safely used in heart transplantation to expand the donor pool. J Am Coll Cardiol 2008; 51: 1214.
15. Seiler C, Laske A, Gallino A, et al. Echocardiographic evaluation of left ventricular wall motion before and after heart transplantation. J Heart Lung Transplant 1992; 11: 867.
16. Kono T,NishinaT, MoritaH, et al. Usefulnessoflow-dose dobutamine stress echocardiography for evaluating reversibility of brain death-induced myocardial dysfunction. Am J Cardiol 1999; 84: 578.
17. Jeevanandam V, Furukawa S, Prendergast TW, et al. Standard criteria for an acceptable donor heart are restricting heart transplantation. Ann Thorac Surg 1996; 62: 1268.
18. Milano A, Livi U, Casula R, et al. Influence of marginal donors on early results after heart transplantation. Transplant Proc 1993; 25: 3158.
19. Lima B, Rajagopal K, Petersen RP, et al. Marginal cardiac allografts do not have increased primary graft dysfunction inalternate list transplantation. Circulation 2006; 114: I27.
20. Cheung MM, Smallhorn JF, Redington AN,et al. The effects of changes in loading conditions and modulation of inotropic state on the myo-cardial performance index: Comparison with conductance catheter measurements. Eur Heart J 2004; 25: 2238.
21. Venkateswaran RV, Ganesh JS, Thekkudan J, et al. Donor cardiac troponin-I:Abiochemical surrogate ofheart function. EurJ Cardiotho-rac Surg 2009; 36: 286.
22. Olszewski R, Timperley J, Szmigielski C, et al. The clinical applications of contrast echocardiography. Eur J Echocardiogr 2007; 8: S13.
23. Marelli D, Laks H, Bresson S, et al. Results after transplantation using donor hearts with preexisting coronary artery disease. J Thorac Cardio-vasc Surg 2003; 126: 821.
24. Zaroff JG, Babcock WD, Shiboski SC, et al. Temporal changes in left ventricular systolic function in heart donors: Results of serial echocar-diography. J Heart Lung Transplant 2003; 22: 383.
25. Randell TT, Hockerstedt KA. Triiodothyronine treatment in brain-dead multiorgan donors\A controlled study. Transplantation 1992; 54: 736.